Hologic Stock Today

HOLX Stock  USD 77.35  1.18  1.55%   

Performance

10 of 100

 
Low
 
High
OK

Odds Of Distress

Less than 5

 
100  
 
Zero
Very Low
Hologic is trading at 77.35 as of the 28th of March 2024; that is 1.55 percent up since the beginning of the trading day. The stock's open price was 76.17. Hologic has under 5 % chance of experiencing financial distress over the next 2 years and had a ok performance during the last 90 days. Equity ratings for Hologic are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
21st of June 1990
Category
Healthcare
Classification
Health Care
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. The company has 234.73 M outstanding shares of which 4.65 M shares are currently shorted by private and institutional investors with about 2.7 trading days to cover. More on Hologic

Moving against Hologic Stock

  0.77FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.77SSY SunLink Health SystemsPairCorr
  0.76NEOG Neogen Report 4th of April 2024 PairCorr
  0.73DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.67TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.65DH Definitive Healthcare Financial Report 2nd of May 2024 PairCorr
  0.56MBOT Microbot Medical Earnings Call TomorrowPairCorr

Hologic Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hologic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hologic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Hologic's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Hologic's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanJay Stein
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Obamacare Repeal, SRI Sustainable Growth, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Analysts covering Hologic report their recommendations after researching Hologic's financial statements, talking to executives and customers, or listening in on Hologic's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Hologic. The Hologic consensus assessment is calculated by taking the average forecast from all of the analysts covering Hologic.
Financial Strength
Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Hologic is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.03370.0574
Way Down
Pretty Stable
Asset Turnover0.760.51
Way Up
Very volatile
Gross Profit Margin0.390.46
Fairly Down
Very volatile
Total Current Liabilities1.5 B1.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities TotalB3.4 B
Way Down
Slightly volatile
Total Assets11 B10.5 B
Sufficiently Up
Slightly volatile
Total Current Assets5.1 B4.8 B
Sufficiently Up
Slightly volatile
Hologic's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hologic's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Hologic's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Hologic's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hologic's financial leverage. It provides some insight into what part of Hologic's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Hologic's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Hologic deploys its capital and how much of that capital is borrowed.
Liquidity
Hologic cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.82 B in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Hologic has a current ratio of 3.82, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Hologic until it has trouble settling it off, either with new capital or with free cash flow. So, Hologic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hologic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hologic to invest in growth at high rates of return. When we think about Hologic's use of debt, we should always consider it together with cash and equity.

Net Income

550.62 Million
Hologic (HOLX) is traded on NASDAQ Exchange in USA. It is located in 250 Campus Drive, Marlborough, MA, United States, 01752 and employs 6,990 people. Hologic is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hologic's market, we take the total number of its shares issued and multiply it by Hologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hologic conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 234.73 M outstanding shares of which 4.65 M shares are currently shorted by private and institutional investors with about 2.7 trading days to cover. Hologic currently holds about 2.39 B in cash with 1.05 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.59.
Check Hologic Probability Of Bankruptcy
Ownership Allocation
Hologic secures a total of 234.73 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Hologic Ownership Details

Hologic Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Hologic jumping above the current price in 90 days from now is roughly 2.18%. The Hologic probability density function shows the probability of Hologic stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Hologic has a beta of 0.3993. This usually indicates as returns on the market go up, Hologic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hologic will be expected to be much smaller as well. Additionally, hologic has an alpha of 0.0736, implying that it can generate a 0.0736 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 77.35HorizonTargetOdds Above 77.35
97.76%90 days
 77.35 
2.18%
Based on a normal probability distribution, the odds of Hologic to move above the current price in 90 days from now is roughly 2.18 (This Hologic probability density function shows the probability of Hologic Stock to fall within a particular range of prices over 90 days) .

Hologic Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Hologic that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Hologic's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Hologic's value.
InstituionRecorded OnShares
Morgan Stanley - Brokerage Accounts2023-12-31
3.4 M
Norges Bank2023-12-31
M
Parnassus Investments, Llc2023-12-31
2.9 M
Northern Trust Corp2023-12-31
2.7 M
Goldman Sachs Group Inc2023-12-31
2.6 M
Dimensional Fund Advisors, Inc.2023-12-31
2.5 M
Amvescap Plc.2023-12-31
2.4 M
Legal & General Group Plc2023-12-31
2.4 M
Manufacturers Life Insurance Co2023-12-31
2.2 M
Vanguard Group Inc2023-12-31
27.7 M
Blackrock Inc2023-12-31
24.3 M
View Hologic Diagnostics

Hologic Historical Income Statement

Hologic Income Statement is one of the three primary financial statements used for reporting Hologic's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Hologic revenue and expense. Hologic Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Hologic's Net Income is fairly stable compared to the past year. Income Tax Expense is likely to rise to about 265.8 M in 2024, whereas Interest Expense is likely to drop slightly above 110.1 M in 2024. View More Fundamentals

Hologic Stock Against Markets

Picking the right benchmark for Hologic stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hologic stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hologic is critical whether you are bullish or bearish towards Hologic at a given time. Please also check how Hologic's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hologic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Hologic Corporate Directors

Hologic corporate directors refer to members of a Hologic board of directors. The board of directors generally takes responsibility for the Hologic's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Hologic's board members must vote for the resolution. The Hologic board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Wayne WilsonIndependent DirectorProfile
Namal NawanaDirectorProfile
Sally CrawfordIndependent DirectorProfile
Ludwig HantsonDirectorProfile

How to buy Hologic Stock?

Before investing in Hologic, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hologic. To buy Hologic stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hologic. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Hologic stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Hologic stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Hologic stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hologic, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Already Invested in Hologic?

The danger of trading Hologic is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hologic is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hologic. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hologic is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.373
Earnings Share
2.11
Revenue Per Share
16.228
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0649
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.